Impact of high-cost drugs for individual patient use

Journal of Pharmacy Practice and Research

Volumn 34, Issue 2, 2004, Pages 100-103

  Gallego, Gisselle ^a   Melocco, Terry ^b   Taylor, Susan J ^a   Brien, Jo Anne E ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA2A INTERFERON; BASILIXIMAB; CYCLOSPORIN; DORNASE ALFA; ENOXAPARIN; ERYTHROPOIETIN; GABAPENTIN; IMATINIB; LINEZOLID; MYCOPHENOLIC ACID; OCTREOTIDE; PACLITAXEL; PAMIDRONIC ACID; TACROLIMUS; VALACICLOVIR;

AUSTRALIA; DATA ANALYSIS; DRUG COST; DRUG USE; FEEDBACK SYSTEM; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE FINANCING; HEALTH CARE UTILIZATION; HOSPITAL RUNNING COST; HUMAN; INFORMATION PROCESSING; MEDICAL DOCUMENTATION; REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME;

EID: 3543028066     PISSN: 1445937X     EISSN: None     Source Type: Journal    
DOI: 10.1002/jppr200434288     Document Type: Review

References (13)

1. Commonwealth Department of Human Services and Health. Schedule of pharmaceutical benefits for approved pharmacists and medical practitioners. Canberra: Publications Unit; 2001.
2. Victorian Government Department of Human Services. Victoria-public hospitals and mental health services policy funding guidelines 2002-2003. Melbourne: Victorian Government Department of Human Services; 2002. Available from: 〈www.health.vic.gov.au/pfg2002/sectiona.pdf〉.
3. Donato R, Scotton R. The Australian health care system. In: Mooney G, Scotton R, editors. Economics and Australian health policy. Sydney: Allen & Unwin; 1999. p. 20-39.
4. Allinson Y. Funding of pharmaceuticals in public hospitals: PBS under the probe. Healthcover 2001; 11(2).
5. Macintyre RC, Sindhusake D, Rubin G. Modeling strategies for reducing pharmaceutical costs in hospital. Int J Quality in Health Care 2001; 13: 63-9.
6. Pacey S, Li Wan Po A. A review of methods of drug cost management in hospitals. J Clin Pharm Therapeutics 1998; 23: 171-77.
7. Commonwealth Department of Health and Aged Care. Schedule of pharmaceutical benefits. Canberra: Publications Unit; 1999.
8. Commonwealth Department of Health and Aged Care. Schedule of pharmaceutical benefits. Canberra: Publications Unit; 2000.
9. Commonwealth Department of Health and Aged Care. Schedule of pharmaceutical benefits. Canberra: Publications Unit; 2001.
10. Australian Medicines Handbook Pty Ltd. Australian Medicines Handbook. Adelaide: Australian Medicines Handbook Pty Ltd; 2000.
11. Capp S, Savage S, Valerie C. Exploring distributive justice in health care. Aust Health Rev 2001; 24: 40-44.
12. Harvery R. And on the cover of the guide were two words in red-don't panic. Aust Health Rev 2001; 24: 15-20.
13. Hill S, Mitchell AS, Henry D. Problems with interpretation of pharmacoeconomic analyses: a review of submissions to the Australian pharmaceutical benefits scheme. JAMA 2000; 283: 2116-21.